US EditionPublished • loading... • Updated
AI technology aids early breast cancer detection
The MammoScreen AI tool helps detect up to 38.5% of breast cancers up to two years earlier, improving diagnosis accuracy without added cost to patients.
- On Thursday, Dr. Richard Gates, Co‑Chief Medical Officer at Axia Women’s Health, discussed how the FDA‑cleared MammoScreen, used since August, analyzes mammograms alongside radiologists on Daybreak.
- Trained on millions of mammograms, AI systems recognize subtle patterns the human eye misses, Dr. Juliette The, radiologist at Baptist Health South Florida, explains.
- According to studies, Axia Women’s Health says MammoScreen can detect up to 38.5% of cancers two years early, recent trials found AI with radiologists detects 20% more cancers without increasing false positives.
- After calcifications were found, clinicians treating Delgado planned to remove the area and plant radioactive seeds, leading to a successful surgery and improved survival chances.
- Early detection matters because it enables earlier treatment and better outcomes, Dr. Richard Gates emphasizes; MammoScreen adds no cost and insurance covers mammograms, while tumor boards review cases weekly and screening starts at age 40.
Insights by Ground AI
17 Articles
17 Articles
Coverage Details
Total News Sources17
Leaning Left1Leaning Right0Center15Last UpdatedBias Distribution94% Center
Bias Distribution
- 94% of the sources are Center
94% Center
C 94%
Factuality
To view factuality data please Upgrade to Premium
